Thermo Fisher launches SARS-CoV-2 GlobalAccess Sequencing Program

By The Science Advisory Board staff writers

May 7, 2020 -- Thermo Fisher Scientific is providing 50 units of its Ion Torrent Genexus system at a subsidized price to support global COVID-19 research as part of its SARS-CoV-2 GlobalAccess Sequencing Program.

The program will be available to research consortia and industry groups battling the spread of SARS-CoV-2. This initiative follows the company's introduction of its Ion AmpliSeq SARS-CoV-2 research panel optimized for the Torrent Genexus on May 6. The company is increasing its effort to accelerate SARS-CoV-2 research by increasing access to its next-generation sequencing technology.

The GlobalAccess Sequencing Program leverages the company's experience in supporting infectious disease outbreaks and brings its newest sequencing platform to more researchers to help answer important questions associated with the pandemic, Thermo Fisher said.

Thermo Fisher Scientific optimizes NGS platform for COVID-19
To expedite genomic analysis of COVID-19 resurgent strains, Thermo Fisher Scientific has optimized its Ion AmpliSeq SARS-CoV-2 research panel for use...
Thermo Fisher, Hamilton debut DNA test system
Thermo Fisher Scientific and Hamilton have launched an automated DNA sample preparation system that extracts nucleic acids from forensic samples.
Thermo Fisher set to acquire Qiagen after all in $11.5B deal
After an on-and-off courtship, Thermo Fisher Scientific announced it is set to acquire Qiagen in a deal worth $11.5 billion. The transaction will...
Thermo Fisher, NanoPin partner on infectious disease tech
Thermo Fisher Scientific will partner with infectious diseases diagnostic company NanoPin Technologies to develop workflows for liquid chromatography-mass...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter